ArticleBritish journal of cancer2022
Advantages of multi-arm non-randomised sequentially allocated cohort designs for Phase II oncology trials.
Helen Mossop et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it